Trine I. Jensen

9.0k total citations · 1 hit paper
9 papers, 6.6k citations indexed

About

Trine I. Jensen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Trine I. Jensen has authored 9 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Trine I. Jensen's work include CRISPR and Genetic Engineering (5 papers), Pluripotent Stem Cells Research (3 papers) and MicroRNA in disease regulation (3 papers). Trine I. Jensen is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), Pluripotent Stem Cells Research (3 papers) and MicroRNA in disease regulation (3 papers). Trine I. Jensen collaborates with scholars based in Denmark, Austria and United States. Trine I. Jensen's co-authors include Thomas B. Hansen, Jørgen Kjems, Christian Kroun Damgaard, Jesper B. Bramsen, Bente Finsen, Bettina Hjelm Clausen, Rasmus O. Bak, Morten T. Venø, Anne Schaefer and Marie S. Ostenfeld and has published in prestigious journals such as Nature, Nature Communications and Genome Research.

In The Last Decade

Trine I. Jensen

9 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural RNA circles function as efficient microRNA sponges

2013 6.2k citations Thomas B. Hansen, Trine I. Jensen et al. Nature profile →

Peers

Countries citing papers authored by Trine I. Jensen

Since Specialization

Citations

This map shows the geographic impact of Trine I. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trine I. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trine I. Jensen more than expected).

Fields of papers citing papers by Trine I. Jensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trine I. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trine I. Jensen. The network helps show where Trine I. Jensen may publish in the future.

Co-authorship network of co-authors of Trine I. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Trine I. Jensen. A scholar is included among the top collaborators of Trine I. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trine I. Jensen. Trine I. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Orthogonal transcriptional modulation and gene editing using multiple CRISPR-Cas systems 2024 ·Molecular Therapy ·(unknown), (unknown), (unknown), Kasper Mikkelsen, Trine I. Jensen, Rasmus O. Bak	5
2	Enrichment of transgene integrations by transient CRISPR activation of a silent reporter gene 2023 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), Trine I. Jensen, Jessica L. Schneller, Rasmus O. Bak	5
3	CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi 2023 ·Molecular Therapy ·(unknown), Trine I. Jensen, Rasmus O. Bak	67
4	Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi 2021 ·Genome Research ·Trine I. Jensen, (unknown), Zongliang Gao, (unknown), (unknown), (unknown), Anders Laustsen, (unknown), Andreas Reinisch, Rasmus O. Bak	53
5	Therapeutic gene editing in haematological disorders with CRISPR/Cas9 2019 ·British Journal of Haematology ·Trine I. Jensen, (unknown), Rasmus O. Bak	29
6	Argonaute-associated short introns are a novel class of gene regulators 2016 ·Nature Communications ·Thomas B. Hansen, Morten T. Venø, Trine I. Jensen, Anne Schaefer, Christian Kroun Damgaard, Jørgen Kjems	52
7	Natural RNA circles function as efficient microRNA sponges breakdown → 2013 ·Nature ·Thomas B. Hansen, Trine I. Jensen, Bettina Hjelm Clausen, Jesper B. Bramsen, Bente Finsen, Christian Kroun Damgaard, Jørgen Kjems	6239
8	The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer 2011 ·British Journal of Cancer ·(unknown), Jesper B. Bramsen, Marie S. Ostenfeld, Erik D. Wiklund, Niels Fristrup, Shan Gao, Thomas B. Hansen, Trine I. Jensen, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt, Jørgen Kjems	100
9	Experimental canine tracheal grafts with reversible squamous metaplasia. 1977 ·PubMed ·(unknown), Edwin C. Shors, Arthur H. Cohen, Trine I. Jensen, John R. Benfield	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact